In the present study, we found that serum Fuc-Hpt levels were increased in NASH patients and that Fuc-Hpt levels were elevated with increasing hepatocyte ballooning scores. This evidence concerns the gene MRS2 and metabolic dysfunction-associated steatohepatitis.